CSR Advisory Council Meeting Materials & Reports
CSR Advisory Council
Meeting Materials & Reports
Working Groups
September 23, 2024
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
- ENQUIRE 8 - Developmental and Regenerative Biology – Dr. Ray Jacobson, Director, Division of Basic and Integrative Biological Sciences, CSR; Dr. John Bowers, Director, Division of Translational and Clinical Sciences, CSR
- ENQUIRE Initiative Evaluation – Lia Fleming, MPH, Senior Public Health Analyst, CSR; Dr. Bruce Reed, CSR Deputy Director
- Update on CSRAC Working Groups - Reviewer Evaluation – Dr. Delia Olufokunbi-Sam, Director, Division of Neuroscience, Development and Aging, CSR; Lynn Yee, MD, MPH, Associate Professor, Division of Maternal-Fetal Medicine, Feinberg School of Medicine, Northwestern University
- Update on CSRAC Working Groups - Reviewer Recognition – Dr. Kristin Kramer, Director, Office of Communications and Outreach, CSR; Dr. Michelle Janelsins-Benton, Professor Division of Supportive Care in Cancer, Department of Surgery, University of Rochester
- Implementation Activities - Simplifying Review Framework – Dr. Mark Caprara, Chief, Molecular and Cellular Sciences and Technologies Review Branch, CSR; Dr. Lisa Steele, Chief, Epidemiology and Population Health Review Branch, CSR
- Implementation Activities - Revisions to Fellowship Review and Application – Dr. Mufeng Li, Scientific Review Officer, Fellowships: Cell Biology, Developmental Biology, and Bioengineering Study Section, CSR; Dr. Lystranne Maynard-Smith, Scientific Review Officer, Advancing Therapeutics, and Advancing Therapeutics - B Study Section, CSR
- Strengthening Peer Review Through Training: An Update – Dr. Miriam Mintzer, Director, Office of Training and Development, CSR
March 25, 2024
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
- ENQUIRE Cluster 18 Update: Social and Behavioral Sciences – Dr. Valerie Durrant, Director, Division of AIDS, Behavior and Population Sciences, CSR
- Improving NRSA Fellowship Review Update – Dr. Ray Jacobson, Director, Division of Basic and Integrative Biological Sciences, CSR
- Simplifying Review Framework Update – Dr. Lisa Steele, Review Branch Chief, CSR; Dr. Kristin Kramer, Director, Office of Communications and Outreach, CSR; Dr. Miriam Mintzer, Director, Office of Training and Development, CSR
- Interim report: CSRAC Reviewer Evaluation Working Group – Dr. Delia Olufokunbi-Sam, Director, CSR Division of Neuroscience, Development and Aging; Lynn Yee, MD, MPH, Associate Professor, Division of Maternal-Fetal Medicine, Feinberg School of Medicine, Northwestern University
- Interim report: CSRAC Reviewer Recognition Working Group – Dr. Kristin Kramer, Director, Office of Communications and Outreach, CSR; Dr. Michelle Janelsins-Benton, Professor Division of Supportive Care in Cancer, Department of Surgery, University of Rochester
September 18, 2023
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
- Simplified Review Framework: Research Project Grants (RPG) – Dr. Mark Caprara, Chief, Molecular and Cellular Sciences and Technologies Review Branch, CSR; Dr. Brian Hoshaw, Review Chief, NEI; Dr. Lisa Steele, Chief, Epidemiology and Population Health Review Branch, CSR
- Improving NRSA Fellowship Review – Dr. Bruce Reed, CSR Deputy Director; Dr. Alison Gammie, Director of Training, Workplace Development and Diversity, NIGMS; Dr. Ericka Boone, Director, Division of Biomedical Research Workforce, NIH OD
- A Framework for Evaluating Reviewers – Reviewer Evaluation Committee
- Slates: How CSR Selects Members of Standing Study Sections – Dr. Bruce Reed, CSR Deputy Director
- ENQUIRE Cluster 13 – Immunology and Respiratory Systems, Dr. Ross Shonat, Director, Division of Physiological and Pathological Sciences, CSR
March 27, 2023
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
- Peer Review and the Mission of NIH – Dr. Lawrence A. Tabak, Performing the Duties of the NIH Director
- Enquire Evaluation- Brain Disorders: Clinical, Translational, and Neurotechnology – Dr. Delia Olufokunbi-Sam, Director, CSR Division of Neuroscience, Development and Aging
- Reflections on Race, Ethnicity & NIH Research Awards: What We’ve Learned from a Decade of Research – Dr. Donna K. Ginther, Director, Institute for Policy & Social Research, University of Kansas
- Strengthening Peer Review through Training – Dr. Miriam Mintzer, Director, CSR Office of Training and Development
Final Reports
September 19, 2022
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
- NRSA Fellowship Workgroup Update – Dr. Bruce Reed, Deputy Director, CSR – Dr. Elizabeth Villa, Associate Professor, Molecular Biology, University of California San Diego
- CSR’s Data Analytics and Technology Support – Dr. Dipak Bhattacharyya, Director of DPAIM, CSR
Final Reports
March 28, 2022
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
- Introduction to the CSR Communications Office – Dr. Kristin Kramer, Director, Office of Communications & Outreach, CSR
- ENQUIRE Cluster 14 Microbiology and Infectious Disease – Dr. Ross D. Shonat, Director, Division of Physiological and Pathological Sciences, CSR
- ENQUIRE Cluster 10 Drug Discovery – Dr. Ray Jacobson, Director, Division of Basic and Integrative Biology, CSR
- Reviewer Feedback on Bias Training – Dr. Hope Cummings, Senior Social Science Analyst, CSR
- NRSA Fellowship Workgroup Update – Dr. Bruce Reed, Deputy Director, CSR – Dr. Elizabeth Villa, Associate Professor, Molecular Biology, University of California San Diego
Final Reports
September 27, 2021
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
- ENQUIRE Recommendations: Oncology Study Sections – Dr. John Bowers, Director, Division of Translational and Clinical Sciences, CSR
- ENQUIRE Recommendations: Epidemiology and Population Sciences Study Sections – Dr. Valerie Durrant, Director, Division of AIDS, Behavior and Population Sciences, CSR
- CSR Strategic Planning – Dr. Delia Olufokunbi Sam, Director, Division of Neuroscience, Development and Aging, CSR
March 29, 2021
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
- Simplifying Review Criteria for Clinical Trials Working Group –
Co-Chairs - Dr. Bruce Reed, CSR Deputy Director and Dr. Tonya Palermo, University of Washington, CSR Advisory Council Member
CSR Advisory Council Members - Dr. Alfred George, Northwestern University and Dr. Yasmin Hurd, Mount Sinai School of Medicine
Ad-hocs - Dr. Brian Boyd, University of Kansas; Dr. Matthew Carpenter, Medical University of South Carolina; Dr. Michelle Janelsins, University of Rochester; Dr. Brooks King-Casas, Virginia Tech University; Dr. Pamela Munster, University of California San Francisco
NIH Staff - Dr. Sally Amero, NIH Review Policy Officer, Office of Extramural Research - ENQUIRE Recommendations: Molecular and Cellular Biology Study Sections - Dr. Ray Jacobson, Director, Division of Basic and Integrative Biology, CSR
Final Reports
September 21, 2020
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
- Simplifying Review Criteria for Clinical Trials Working Group –
Co-Chairs: Dr. Bruce Reed, CSR Deputy Director and Dr. Tonya Palermo, University of Washington, CSR Advisory Council Member
CSR Advisory Council Members - Dr. Alfred George, Northwestern University and Dr. Yasmin Hurd, Mount Sinai School of Medicine
Ad-hocs - Dr. Brian Boyd, University of Kansas; Dr. Matthew Carpenter, Medical University of South Carolina; Dr. Brooks King-Casas, Virginia Tech University; Dr. Pamela Munster, University of California San Francisco
NIH Staff - Dr. Sally Amero, NIH Review Policy Officer, Office of Extramural Research - Public Forums on Racial Disparities in NIH Funding – Dr. Bruce Reed, CSR Deputy Director
Final Reports
Public Forums on Racial Disparities in NIH Funding
CSR held three public forums in July to discuss racial disparities in NIH funding and potential bias in peer review. The report below summarizes the comments CSR received through these public forums and via email following the forums.
March 30, 2020
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director: Slides & Video
- CSR Advisory Council Workgroup: Simplifying Review Criteria – Dr. Bruce Reed, CSR Deputy Director & Dr. Tonya Palermo, University of Washington, CSR Advisory Council Member: Slides & Video
Final Reports
ENQUIRE 2019
These reports detail the changes in scientific scope for study sections evaluated under the ENQUIRE process in 2019. ENQUIRE integrates data and input from multiple stakeholders – the external scientific community, extramural programs at NIH, and CSR staff to consider changes necessary to facilitate the identification of high impact science, with special consideration of emerging science. The changes in scientific scope detailed in these reports will be implemented for grant applications submitted for Oct 2020 grant deadlines and beyond.
- Cardiac, Vascular, and Hematologic Sciences
- Gastrointestinal, Renal, and Endocrine Systems
- Functional/Cognitive Neuroscience
- Healthcare Delivery & Patient Outcomes
Simplifying Review Criteria Working Group
A group was convened in 2020 to consider ways in which review criteria could be changed to reduce reviewer burden while facilitating the identification of high impact science (Review Matters, Feb 27, 2020). This report summarizes the recommendations of the working group and CSR Advisory Council and next steps.
September 23, 2019
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, Ph.D., CSR Director
- ENQUIRE Group 16 – Healthcare Delivery and Patient Management – Dr. Valerie Durrant, Ph.D., CSR DABP Director
- ENQUIRE Group 9 – Gastroinstestinal, Renal, Endocrine, Metabolism - Dr. Larry Boerboom, Ph.D., CSR DPPS Director
- ENQUIRE Group 6 – Cardiovascular, Vascular, and Hematology – Dr. John Bowers, Ph.D., CSR DTCS Director
- ENQUIRE Group 11 – Functional Neuroscience – Dr. Bruce Reed, Ph.D., CSR DNDA Director
- SRO Training at CSR – Dr. Craig Giroux, Ph.D., CSR New SRO Training and Development Coordinator
- The Cancer Moonshot – Dr. Dinah Singer, Ph.D., Deputy Director, National Cancer Institute
- Early Career Reviewer Working Group –
Co-chairs and CSR Advisory Council Members - Dr. Mark Peifer, Ph.D., University of North Carolina, Chapel Hill and Dr. Elizabeth Villa, University of California San Diego
Ad-hocs - Dr. Vinay Aakalu, M.D., MPH, University of Illinois at Chicago; Dr. Stephanie Cook, Ph.D., MPH, New York University; Dr. Lisa Jones, Ph.D., University of Maryland; Dr. Manuel Llano, M.D., Ph.D., University of Texas El Paso
NIH Staff - Dr. Kristin Kramer, Ph.D., CSR; Dr. Antonello Pileggi, Ph.D., CSR - Review Integrity Training Working Group –
Chair (and CSR AC member) - Dr. Scott Miller, Yale University
CSR AC members - Dr. Jinming Gao, Ph.D., UT Southwestern Medical Center; Dr. Deanna Kroetz, University of California San Francisco; Dr. Tonya Palermo, Ph.D., Seattle Children’s Research Institute; Dr. Denise Wilfley, Ph.D., Washington University St. Louis
NIH Staff - Dr. Kathyrn Koeller, Ph.D., CSR Research & Review Integrity Officer; Dr. Miriam Mintzer, Ph.D., CSR; Dr. Raul Rojas, Ph.D., CSR
Final Reports
Early Career Reviewer Working Group
A working group was convened in 2019 to re-evaluate the Early Career Reviewer Program. The working group was comprised of two CSR Advisory Council members, two CSR scientific review officers, and four members of the scientific community who recently served as ECRs. The working group met in July to discuss possible changes to the program and their report was considered by the CSR Advisory Council on September 23, 2019. The report summarizes the recommendations of the working group and the final recommendations made by CSR Advisory Council.
March 25, 2019
Presentations
- Some Observations from the NIH Director – Dr. Francis S. Collins, M.D., Ph.D., NIH Director
- CSR Advisory Council Update – Dr. Noni Byrnes, Ph.D., CSR Director
- ENQUIRE – Evaluating Panel Quality in Review – Dr. Valerie Durrant, Ph.D., CSR DABP Director
- ENQUIRE – Evaluating Panel Quality in Review – Kidney, Urology, Gastrointestinal, Diabetes, Obesity, Nutrition, and Endocrine Study Sections – Dr. Larry Boerboom, Ph.D., CSR DPPS Director
- External Scientific Review of Study Sections on Biology and Disorders of Vision – Dr. Bruce Reed, Ph.D., CSR DNDA Director
- Council Working Group on Review Integrity – Dr. Kathyrn Koeller, Ph.D., CSR Research & Review Integrity Officer; Dr. Jinming Gao, Ph.D., Professor of Oncology, Pharmacology, and Otolaryngology, UT Southwestern Medical Center; Dr. Denise Wilfley, Ph.D., Professor of Psychiatry, Medicine, and Pediatrics, Washington University St. Louis; Dr. Miriam Mintzer, Ph.D., CSR; Dr. Paul Rojas, Ph.D., CSR
- 3 Step Prize Review: Antimicrobial Resistance Diagnostics Challenge – Dr. Gagan Pandya, Ph.D., CSR; Dr. Alex Politis, Ph.D., CSR IDM Chief
- Nomination Slates – Dr. Bruce Reed, Ph.D., CSR DNDA Director
September 24, 2018
Presentations
- CSR Advisory Council Update – Dr. Noni Byrnes, CSR Acting Director
- Managing Review Burden – Dr. Valerie Durrant, CSR DABP Division Director; Dr. Ying-Yee Kong, CSR IFCN Scientific Review Officer; Dr. Miriam Mintzer, CSR RPHB Scientific Review Officer
- High Risk/High Reward Reviews
- CSR Review of the NIH Common Fund High Risk-High Reward Research Award Programs – Dr. Ray Jacobson, CSR BCMB Chief
- NIH Director’s Early Independence Award Review – Dr. Weijia Ni, CSR RPHB Chief; Dr. Suzanne Ryan, CSR PSE Scientific Review Officer
- NIH Director’s New Innovator Award – Dr. Srikanth Ranganathan, CSR MOSS Scientific Review Officer
- NIH’s All of Us Program – Dr. Joni Rutter, Director of Scientific Programs, NIH All of Us Research Program
- Expectations and Characteristics of the Peer Review of Grant Applications – Dr. Stephen Gallo, Chief Scientist, American Institute of Biological Sciences
- CSR Outreach Update – Dr. Bruce Reed, CSR DNDA, Division Director
- CSR Strategic Plan: Input and Discussion – Dr. Christine Melchior, Senior Advisor to the CSR Director
